Personalized Cell Therapy Market Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

 

Personalized Cell Therapy Market
Personalized Cell Therapy Market 

Personalized cell therapy refers to the treatment of various diseases such as cancer and autoimmune diseases by injecting living cells into a patient's body. Platelet transfusions, bone marrow transplantation, whole blood transfusions, packed red cell transfusions, and organ transplantation are some of its applications. It is used to treat a variety of chronic conditions, including Parkinson's disease and amyotrophic lateral sclerosis (both neurodegenerative diseases), spinal cord injuries, diabetes, and cancer.

Rising chronic disease prevalence and cancer incidence are expected to drive growth in the global personalized cell therapy market over the forecast period. According to the National Cancer Institute (NCI), an estimated 15.5 million cancer cases were reported in the United States in 2016. Furthermore, according to the NCI, approximately 15,270 children and adolescents aged 0 to 19 were diagnosed with cancer in the United States in 2017.

Manufacturers are conducting numerous clinical trials to develop novel personalized cell therapy market for chronic diseases such as cancer, diabetes, and other autoimmune diseases. For example, Orgenesis Inc., a developer and provider of advanced cell therapies, received Institutional Review Board (IRB) approval in April 2019 to collect liver biopsies from patients at Rambam Medical Center in Haifa, Israel. The sample will be collected in order to confirm the safety and efficacy of liver cells for personalised cell replacement therapy in patients with insulin-dependent diabetes who have undergone total or partial pancreatectomy. As a result, the global personalised cell therapy market is expected to grow as research studies expand.

Comments

Post a Comment

Popular posts from this blog

The Role of the Foodservice Industry in Driving the French Fries Market

Image
  French Fries Market The food service industry plays a significant role in driving the French fries market, contributing to its growth and popularity worldwide. From fast food chains to restaurants, cafes, and even food trucks, the food service sector heavily relies on French fries as a staple menu item, thereby fueling the demand for this popular snack. One key aspect of the food service industry's impact on the French fries market is its ability to introduce and popularize French fries among consumers. Fast food chains, in particular, have played a crucial role in making French fries a ubiquitous and easily recognizable item on menus worldwide. These chains have an extensive reach, powerful marketing strategies, and a loyal customer base, enabling them to drive consumer preferences and shape market trends. As a result, French fries have become deeply ingrained in fast food culture, contributing to their widespread consumption. Restaurants and food establishments also play a
Read more

Market Share and Revenue Analysis of the Microdermabrasion Devices Market

Image
Microdermabrasion Devices Market   The microdermabrasion devices market has witnessed significant growth in recent years, driven by the increasing demand for non-invasive cosmetic procedures and the growing emphasis on skincare. Analyzing the market share and revenue of key players is crucial for understanding the competitive landscape and identifying growth opportunities within the industry. The market share of microdermabrasion device manufacturers is influenced by several factors, including product offerings, brand reputation, distribution networks, and strategic partnerships. Established players such as Johnson & Johnson Services Inc., Silhouet-Tone, Advanced Microderm, Dermaglow, and Altair Instruments Inc. have established a strong presence in the market, leveraging their extensive product portfolios and brand recognition to capture a significant share. Market share can vary across regions, with different players dominating in different geographical areas. For example, a
Read more

Analyzing the Global Meningococcal Vaccines Market: Size, Share, and Forecast

Image
  Meningococcal Vaccines Market The global meningococcal vaccine market has witnessed significant growth in recent years due to the rising prevalence of meningococcal infections and the increasing emphasis on preventive healthcare. Analyzing the size, share, and forecast of the market provides valuable insights into its current state and future prospects. In terms of market size, the global meningococcal vaccines market has experienced steady expansion, driven by factors such as the growing global population, increasing disease awareness, and government initiatives promoting vaccination campaigns. The market encompasses various types of vaccines, including conjugate vaccines, polysaccharide vaccines, and combination vaccines, each targeting specific meningococcal serogroups. The market share of different players in the meningococcal vaccines market reflects the competitive landscape and market dynamics. Key pharmaceutical companies such as Pfizer Inc., GlaxoSmithKline (GSK), Sanofi
Read more